JP2016065006A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016065006A5 JP2016065006A5 JP2014194053A JP2014194053A JP2016065006A5 JP 2016065006 A5 JP2016065006 A5 JP 2016065006A5 JP 2014194053 A JP2014194053 A JP 2014194053A JP 2014194053 A JP2014194053 A JP 2014194053A JP 2016065006 A5 JP2016065006 A5 JP 2016065006A5
- Authority
- JP
- Japan
- Prior art keywords
- propionate
- external preparation
- betamethasone
- agonist
- valerate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000556 agonist Substances 0.000 claims 5
- ZIDQIOZJEJFMOH-UHFFFAOYSA-N 7-[3-(3-cyclohexyl-3-hydroxypropyl)-2,5-dioxoimidazolidin-4-yl]heptanoic acid Chemical compound C1CCCCC1C(O)CCN1C(CCCCCCC(O)=O)C(=O)NC1=O ZIDQIOZJEJFMOH-UHFFFAOYSA-N 0.000 claims 4
- 150000003431 steroids Chemical class 0.000 claims 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-M propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims 3
- UREBDLICKHMUKA-DVTGEIKXSA-N Betamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-DVTGEIKXSA-N 0.000 claims 2
- SNHRLVCMMWUAJD-SUYDQAKGSA-N Betamethasone 17-valerate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(OC(=O)CCCC)[C@@]1(C)C[C@@H]2O SNHRLVCMMWUAJD-SUYDQAKGSA-N 0.000 claims 2
- 229960004311 Betamethasone valerate Drugs 0.000 claims 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N Cortisol Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 claims 2
- 229960003957 Dexamethasone Drugs 0.000 claims 2
- UREBDLICKHMUKA-CXSFZGCWSA-N Dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 claims 2
- 208000003251 Pruritus Diseases 0.000 claims 2
- -1 RS93520 Chemical compound 0.000 claims 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N Valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 claims 2
- 229960002537 betamethasone Drugs 0.000 claims 2
- 229960000890 hydrocortisone Drugs 0.000 claims 2
- 230000001629 suppression Effects 0.000 claims 2
- 229940092705 Beclomethasone Drugs 0.000 claims 1
- CIWBQSYVNNPZIQ-XYWKZLDCSA-N Betamethasone dipropionate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O CIWBQSYVNNPZIQ-XYWKZLDCSA-N 0.000 claims 1
- 229960004703 Clobetasol Propionate Drugs 0.000 claims 1
- CBGUOGMQLZIXBE-XGQKBEPLSA-N Clobetasol propionate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CCl)(OC(=O)CC)[C@@]1(C)C[C@@H]2O CBGUOGMQLZIXBE-XGQKBEPLSA-N 0.000 claims 1
- WYQPLTPSGFELIB-JTQPXKBDSA-N Difluprednate Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2CC[C@@](C(=O)COC(C)=O)(OC(=O)CCC)[C@@]2(C)C[C@@H]1O WYQPLTPSGFELIB-JTQPXKBDSA-N 0.000 claims 1
- 229960001347 Fluocinolone Acetonide Drugs 0.000 claims 1
- FEBLZLNTKCEFIT-VSXGLTOVSA-N Fluocinolone acetonide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O FEBLZLNTKCEFIT-VSXGLTOVSA-N 0.000 claims 1
- WJOHZNCJWYWUJD-IUGZLZTKSA-N Fluocinonide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)COC(=O)C)[C@@]2(C)C[C@@H]1O WJOHZNCJWYWUJD-IUGZLZTKSA-N 0.000 claims 1
- FOGXJPFPZOHSQS-AYVLZSQQSA-N Hydrocortisone butyrate propionate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)CC)(OC(=O)CCC)[C@@]1(C)C[C@@H]2O FOGXJPFPZOHSQS-AYVLZSQQSA-N 0.000 claims 1
- 229960001664 Mometasone Drugs 0.000 claims 1
- 229950010765 Pivalate Drugs 0.000 claims 1
- 229960002117 Triamcinolone Acetonide Drugs 0.000 claims 1
- YNDXUCZADRHECN-JNQJZLCISA-N Triamcinolone acetonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O YNDXUCZADRHECN-JNQJZLCISA-N 0.000 claims 1
- SNHRLVCMMWUAJD-OMPPIWKSSA-N [(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] pentanoate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(OC(=O)CCCC)[C@@]1(C)C[C@@H]2O SNHRLVCMMWUAJD-OMPPIWKSSA-N 0.000 claims 1
- ITYMTTQVNYAJAA-OCUNRLNVSA-N [(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(OC(=O)CC)[C@@]1(C)C[C@@H]2O ITYMTTQVNYAJAA-OCUNRLNVSA-N 0.000 claims 1
- FBRAWBYQGRLCEK-AVVSTMBFSA-N [(8S,9R,10S,13S,14S,16S,17R)-17-(2-chloroacetyl)-9-fluoro-10,13,16-trimethyl-3,11-dioxo-7,8,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-17-yl] butanoate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CCl)(OC(=O)CCC)[C@@]1(C)CC2=O FBRAWBYQGRLCEK-AVVSTMBFSA-N 0.000 claims 1
- DGYSDXLCLKPUBR-SLPNHVECSA-N [(8S,9S,10R,11S,13S,14S,17R)-17-(2-acetyloxyacetyl)-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl] pentanoate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(C)=O)(OC(=O)CCCC)[C@@]1(C)C[C@@H]2O DGYSDXLCLKPUBR-SLPNHVECSA-N 0.000 claims 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 1
- NBMKJKDGKREAPL-DVTGEIKXSA-N beclomethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O NBMKJKDGKREAPL-DVTGEIKXSA-N 0.000 claims 1
- 229960004648 betamethasone acetate Drugs 0.000 claims 1
- AKUJBENLRBOFTD-QZIXMDIESA-N betamethasone acetate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(C)=O)(O)[C@@]1(C)C[C@@H]2O AKUJBENLRBOFTD-QZIXMDIESA-N 0.000 claims 1
- 229960001102 betamethasone dipropionate Drugs 0.000 claims 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 claims 1
- 229960005465 clobetasone butyrate Drugs 0.000 claims 1
- 229950000250 dexamethasone dipropionate Drugs 0.000 claims 1
- 229950006825 dexamethasone valerate Drugs 0.000 claims 1
- 229960004875 difluprednate Drugs 0.000 claims 1
- 229950009938 flumetasone pivalate Drugs 0.000 claims 1
- JWRMHDSINXPDHB-OJAGFMMFSA-N flumethasone pivalate Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)COC(=O)C(C)(C)C)(O)[C@@]2(C)C[C@@H]1O JWRMHDSINXPDHB-OJAGFMMFSA-N 0.000 claims 1
- 229940042902 flumethasone pivalate Drugs 0.000 claims 1
- 229960000785 fluocinonide Drugs 0.000 claims 1
- QLIIKPVHVRXHRI-CXSFZGCWSA-N mometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CCl)(O)[C@@]1(C)C[C@@H]2O QLIIKPVHVRXHRI-CXSFZGCWSA-N 0.000 claims 1
- 229950008480 prednisolone valerate acetate Drugs 0.000 claims 1
- 230000000699 topical Effects 0.000 claims 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-M valerate Chemical compound CCCCC([O-])=O NQPDZGIKBAWPEJ-UHFFFAOYSA-M 0.000 claims 1
- 229940070710 valerate Drugs 0.000 claims 1
- 229940005605 valeric acid Drugs 0.000 claims 1
Claims (8)
- ＤＰ１アゴニストとステロイドとを含有する、外用剤。
- 前記ＤＰ１アゴニストがＢＷ２４５Ｃ、ＳＱ２７９８６、ＲＳ９３５２０、ＺＫ１１０８４１、ＺＫ１１８１８２、ＡＳ７０２２２４、およびＡＬ６５９８からなる群から選択される、請求項１に記載の外用剤。
- 前記ＤＰ１アゴニストがＢＷ２４５Ｃである、請求項２に記載の外用剤。
- 前記ステロイドがプロピオン酸クロベタゾール、酢酸ジフロラゾン、フランカルボン酸モメタゾン、酢酸プロピオン酸ベタメタゾン、プロピオン酸デキサメタゾン、ジプロピオン酸ベタメタゾン、ジフルプレドナート、フルオシノニド、酪酸プロピオン酸ヒドロコルチゾン、アムシノニド、吉草酸ジフルコルトロン、吉草酸ベタメタゾン、プロピオン酸ベクロメタゾン、吉草酸デキサメタゾン、吉草酸酢酸プレドニゾロン、ハルシノニド、フルオシノロンアセトニド、プロピオン酸デプロドン、トリアムシノロンアセトニド、ピバル酸フルメタゾン、プロピオン酸アルクロメタゾン、酪酸クロベタゾン、酪酸ヒドロコルチゾン、デキサメタゾン、プレドニゾロン、およびヒドロコルチゾンからなる群から選択される、請求項１〜３のいずれか１項に記載の外用剤。
- 前記ＤＰ１アゴニストと前記ステロイドとを、モル比１：５００〜６：１の割合で含む、請求項１〜４のいずれか１項に記載の外用剤。
- ＢＷ２４５Ｃと吉草酸ベタメタゾンとを含有し、前記吉草酸ベタメタゾンにより誘発される掻痒の抑制に用いられる、外用剤。
- 前記ＢＷ２４５Ｃと前記吉草酸ベタメタゾンとを、モル比１：５００〜６：１の割合で含む、請求項６に記載の外用剤。
- ＤＰ１アゴニストを用いることを特徴とする、ステロイド外用剤により誘発される掻痒の抑制方法。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014194053A JP2016065006A (ja) | 2014-09-24 | 2014-09-24 | Ｄｐ１アゴニストとステロイドとを含有する外用剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014194053A JP2016065006A (ja) | 2014-09-24 | 2014-09-24 | Ｄｐ１アゴニストとステロイドとを含有する外用剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016065006A JP2016065006A (ja) | 2016-04-28 |
| JP2016065006A5 true JP2016065006A5 (ja) | 2017-11-02 |
Family
ID=55804944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014194053A Pending JP2016065006A (ja) | 2014-09-24 | 2014-09-24 | Ｄｐ１アゴニストとステロイドとを含有する外用剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2016065006A (ja) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003070252A (ja) * | 2001-06-14 | 2003-03-07 | Fuji Electric Co Ltd | 電力変換装置の駆動電源回路 |
-
2014
- 2014-09-24 JP JP2014194053A patent/JP2016065006A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012532889A5 (ja) | ||
| WO2018089373A3 (en) | Steroids and protein-conjugates thereof | |
| JP2018197259A5 (ja) | ||
| CO2017003396A2 (es) | Esteroides neuroactivos, composiciones y usos de los mismos | |
| MX2020006994A (es) | Esteroides y conjugados de anticuerpos de los mismos. | |
| RU2013128607A (ru) | Фармацевтические составы, содержащие кортикостероиды, для топикального применения | |
| MX2018011706A (es) | Composicion farmaceutica de hormona esteroide. | |
| HRP20201307T1 (hr) | Upotreba reslizumaba za liječenje umjerene do ozbiljne eozinofilne astme | |
| PH12017500239A1 (en) | Abiraterone acetate formulation and methods of use | |
| CA3037257C (en) | Pharmaceutical compositions comprising beclomethasone dipropionate, and formoterol fumarate dihydrate | |
| AR123674A2 (es) | Composición farmacéutica en aerosol de formoterol y dipropionato de beclometasona | |
| RU2014113906A (ru) | Терапевтическое применение эктоина | |
| JP2014526448A5 (ja) | ||
| PE20180489A1 (es) | Soluciones de esteroide neuroactivo y sus metodos de uso | |
| AR096459A1 (es) | Composiciones de corticosteroides y método de fabricación | |
| JP2016065006A5 (ja) | ||
| AR089839A1 (es) | Composicion farmaceutica que combina cloruro de dietil-[6-(4-hidroxicarbamoil-fenil-carbamoiloxi-metil)-naftalen-2-il-metil]-amonio y al menos un agente activo antiinflamatorio para su uso en tratamiento de distrofia muscular | |
| JP2016520656A5 (ja) | ||
| LT3768241T (lt) | Vietinė kompozicija, apimanti kalcipotriolį ir betametazono dipropionatą | |
| UY36948A (es) | Formulaciones de corticosteroides para mantener concentraciones de corticosteroide en el líquido sinovial | |
| WO2018232007A8 (en) | Potent soft anti-inflammatory corticosteroid compounds and uses thereof | |
| JP2015034162A5 (ja) | ||
| WO2011101828A8 (en) | A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and betamethasone, and a process to make it | |
| MY197560A (en) | Pulmonary delivery of progestogen | |
| WANG et al. | UPLC-MS/MS determination of 21 glucocorticoids in cosmetics |